시장보고서

상품코드

1532825

세포 및 유전자 치료 제조 서비스 시장 : 치료 유형별, 세포 유형별, 서비스 유형별, 최종사용자별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

Cell and Gene Therapy Manufacturing Services Market, By Therapy Type, By Cell Type, By Service Type, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

발행일: 2024년 07월 | 리서치사:

AnalystView Market Insights | 페이지 정보: 영문 399 Pages | 배송안내 : 2-3일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

세포 및 유전자 치료 제조 서비스 시장 규모는 2023년 59억 7,700만 달러로 2024-2032년 연평균 17.2% 성장할 것으로 예상됩니다.

세포 및 유전자 치료 제조 서비스 시장 - 시장 역학

유전자 질환과 암의 유병률 증가로 세포 및 유전자 치료 제조 서비스의 필요성이 높아짐

유전성 질환과 암의 유병률 증가는 세포 및 유전자 치료 제조 서비스에 대한 수요를 크게 촉진하고 있습니다. 예를 들어, 미국 국립암연구소(National Cancer Institute)의 보고서에 따르면, 2024년 미국에서만 약 190만 명의 암 환자가 새로 발생할 것으로 예상되며, 이는 첨단 치료 솔루션에 대한 긴급한 수요를 강조하고 있습니다. 마찬가지로 세계보건기구(WHO)는 전 세계 인구의 약 20명 중 1명이 유전성 질환을 앓고 있어 전문적인 치료법의 필요성이 높아지고 있다고 지적합니다. 이 분야에 대한 최근 투자는 주목할 만하며, 미국 국립보건원은 지난해 유전자 치료 연구에 10억 달러 이상의 보조금을 배정했습니다. 또한, Novartis와 Bluebird Bio와 같은 대기업은 이러한 첨단 치료에 대한 수요 증가에 대응하기 위해 제조 능력을 확장하고 있으며, 이는 혁신적인 치료를 통해 환자 결과를 개선하는 데 대한 관심이 증가하고 있음을 반영합니다.

세포 및 유전자 치료 제조 서비스 시장 - 주요 인사이트

당사의 리서치 애널리스트의 분석에 따르면, 세계 시장은 예측 기간(2024-2032년) 동안 연평균 약 17.2%의 성장률을 보일 것으로 예상됩니다.

치료 유형별로는 유전자 치료가 2023년 가장 큰 시장 점유율을 차지할 것으로 예측되었습니다.

세포 유형별로는 2023년에는 자가세포가 주요 유형으로 부상했습니다.

서비스 유형별로는 CDMO(Contract Development and Manufacturing Organization)가 2023년 주요 유형으로 꼽혔습니다.

지역별로는 북미가 2023년 매출 1위

세포 및 유전자 치료 제조 서비스 시장 - 세분화 분석:

세포 및 유전자 치료 제조 서비스 세계 시장은 치료 유형, 세포 유형, 서비스 유형, 최종사용자 및 지역에 따라 세분화됩니다.

시장은 치료 유형에 따라 세포 치료와 유전자 치료의 두 가지 범주로 나뉩니다. 세포 치료는 치료용 세포의 생산과 조작에 중점을 두고, 유전자 치료는 유전 물질을 변화시켜 질병에 대처하는 치료법 개발에 관여합니다.

시장은 세포 유형에 따라 '자가 세포'와 '동종 세포'의 두 가지 범주로 나뉩니다. 반면 동종세포는 공여자로부터 공급되는 세포로 더 넓은 응용 가능성을 가지고 있습니다.

세포 및 유전자 치료 제조 서비스 시장 - 지리적 인사이트

북미, 특히 미국은 첨단 연구 인프라, 풍부한 자금, 전문 제조 시설의 탄탄한 네트워크를 바탕으로 시장을 선도하고 있습니다. 유럽에서는 독일과 영국과 같은 국가들도 강력한 규제 프레임워크와 생명공학 기업과 연구기관의 협력 관계 증가 등의 혜택을 누리고 있는 중요한 시장 진입국입니다. 한편, 아시아태평양은 빠르게 부상하고 있으며, 중국과 일본과 같은 국가들이 생명공학 혁신에 많은 투자를 하고 제조 능력을 확대하고 있습니다. 예를 들어, 중국이 최근 유전자 치료 인프라에 5억 달러를 투자한 것은 중국이 이 분야의 주요 진입자가 되기 위해 집중하고 있음을 반영합니다.

세포 및 유전자 치료 제조 서비스 시장 - 경쟁 상황:

Lonza, Catalent, WuXi AppTec과 같은 주요 기업들은 광범위한 제조 능력과 전 세계에 진출해 세포 가공에서 유전자 편집에 이르기까지 다양한 서비스를 제공하며 시장을 장악하고 있습니다. 이들 기업은 첨단 기술에 대한 막대한 투자와 전략적 파트너십을 통해 강화되고 있습니다. 예를 들어, 론자와 노바티스(Novartis)가 CAR-T 세포 치료제 제조 역량을 강화하기 위해 맺은 제휴는 업계 제휴가 심화되는 추세를 잘 보여줍니다. 신생 바이오테크 기업 및 위탁생산(CMO)도 전문 서비스를 제공하고 혁신을 촉진하는 데 있어 중요한 역할을 하고 있습니다. 경쟁 환경은 끊임없는 기술 발전, 규제 변화, 확장 가능하고 효율적인 제조 솔루션에 대한 강조로 특징지어집니다.

소개
북미
- 개요
- 북미의 주요 제조업체
- 미국
- 캐나다
유럽
- 개요
- 유럽의 주요 제조업체
- 독일
- 이탈리아
- 영국
- 프랑스
- 러시아
- 네덜란드
- 스웨덴
- 폴란드
- 기타
아시아태평양
- 개요
- 아시아태평양의 주요 제조업체
- 인도
- 중국
- 일본
- 한국
- 호주
- 태국
- 인도네시아
- 필리핀
- 기타
라틴아메리카
- 개요
- 라틴아메리카의 주요 제조업체
- 브라질
- 멕시코
- 아르헨티나
- 콜롬비아
- 기타
중동 및 아프리카
- 개요
- 중동 및 아프리카의 주요 제조업체
- 사우디아라비아
- 아랍에미리트
- 이스라엘
- 터키
- 알제리
- 이집트
- 기타

제12장 주요 벤더 분석 - 세포 및 유전자 치료 제조 서비스 업계

경쟁 대시보드
기업 개요
- Adaptimmune Therapeutics plc
- Bluebird Bio, Inc.
- Catalent, Inc.
- Celyad Oncology SA
- Charles River Laboratories International, Inc.
- Gene Therapy Research Group
- Kiadis Pharma NV
- Lonza Group AG
- MaxCyte, Inc.
- Miltenyi Biotec GmbH
- Orchard Therapeutics plc
- Rocket Pharmaceuticals, Inc.
- Sangamo Therapeutics, Inc.
- Sarepta Therapeutics, Inc.
- TCR2 Therapeutics Inc.
- WuXi AppTec
- 기타

제13장 애널리스트의 전방위 전망

ksm 24.09.03

REPORT HIGHLIGHT

Cell and Gene Therapy Manufacturing Services Market size was valued at USD 5,977 Million in 2023, expanding at a CAGR of 17.2% from 2024 to 2032.

The Cell and Gene Therapy Manufacturing Services Market encompasses specialized services for the production of cell and gene therapies, which are revolutionary treatments targeting genetic disorders and various diseases. The rising prevalence of genetic disorders and cancer, coupled with advancements in personalized medicine, is fueling the market's expansion. However, challenges such as high production costs and complex regulatory requirements act as significant restraints. Opportunities are emerging in the form of increased investments in research and development, with global funding for cell and gene therapies having surged by approximately 30% in the past year. Additionally, partnerships between biotech firms and contract manufacturing organizations (CMOs) are on the rise, aiming to streamline production processes and enhance scalability.

Cell and Gene Therapy Manufacturing Services Market- Market Dynamics

Growing Prevalence of Genetic Disorders and Cancer Fuels Need for Cell and Gene Therapy Manufacturing Services

The increasing prevalence of genetic disorders and cancer is significantly driving the demand for Cell and Gene Therapy Manufacturing Services. For instance, the National Cancer Institute reports that nearly 1.9 million new cancer cases were expected in the U.S. alone in 2024, underscoring the urgent need for advanced therapeutic solutions. Similarly, the World Health Organization notes that genetic disorders affect about 1 in 20 people globally, amplifying the need for specialized therapies. Recent investments in this field have been notable, with the National Institutes of Health allocating over $1 billion in grants for gene therapy research in the past year. Additionally, leading companies like Novartis and Bluebird Bio have expanded their manufacturing capabilities to meet the rising demand for these cutting-edge treatments, reflecting a growing focus on improving patient outcomes through innovative therapies.

Cell and Gene Therapy Manufacturing Services Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 17.2% over the forecast period (2024-2032)

Based on Therapy Type segmentation, Gene Therapy was predicted to show maximum market share in the year 2023

Based on Cell Type segmentation, Autologous Cells was the leading type in 2023

Based on Service Type segmentation, Contract Development and Manufacturing Organization (CDMO) was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Cell and Gene Therapy Manufacturing Services Market- Segmentation Analysis:

The Global Cell and Gene Therapy Manufacturing Services Market is segmented based on Therapy Type, Cell Type, Service Type, End-User, and Region.

The market is divided into two categories based on Therapy Type: Cell Therapy and Gene Therapy. Cell Therapy focuses on the production and manipulation of cells for therapeutic use, while Gene Therapy involves the development of treatments that alter genetic material to address diseases.

The market is divided into two categories based on Cell Type: Autologous Cells and Allogeneic Cells. Autologous Cells are derived from the patient's own body, ensuring compatibility, while Allogeneic Cells are sourced from donors and offer broader application potential.

Cell and Gene Therapy Manufacturing Services Market- Geographical Insights

North America, particularly the United States, leads the market due to its advanced research infrastructure, substantial funding, and a robust network of specialized manufacturing facilities. In Europe, countries such as Germany and the United Kingdom are also significant players, benefiting from strong regulatory frameworks and increasing collaboration between biotech companies and research institutions. Meanwhile, the Asia-Pacific region is emerging rapidly, with countries like China and Japan investing heavily in biotech innovations and expanding their manufacturing capabilities. For example, China's recent $500 million investment in gene therapy infrastructure reflects its growing focus on becoming a major player in this sector.

Cell and Gene Therapy Manufacturing Services Market- Competitive Landscape:

Key players such as Lonza, Catalent, and WuXi AppTec dominate the market with extensive manufacturing capabilities and global reach, providing a range of services from cell processing to gene editing. These companies are bolstered by significant investments in cutting-edge technologies and strategic partnerships. For instance, Lonza's collaboration with Novartis to enhance manufacturing capacity for CAR-T cell therapies highlights the trend towards deepening industry alliances. Emerging biotech firms and contract manufacturing organizations (CMOs) also play a crucial role, offering specialized services and driving innovation. The competitive environment is characterized by continuous advancements in technology, regulatory adaptations, and an emphasis on scalable and efficient manufacturing solutions.

Recent Developments:

In May 2024, ProPharma, in collaboration with PBL, introduced the Cell Factory Box (CF Box), a fully automated and enclosed cell factory device designed for the production of cell and gene therapies (CGTs). The CF Box facilitates decentralized manufacturing of various CGTs within Class D (ISO8) or controlled, non-classified environments.

In May 2024, Bristol Myers Squibb signed a USD 380 million deal with Cellares to produce CAR T-cell therapies, highlighting the rising demand for outsourced cell and gene therapy manufacturing services. Cellares plans to expand its automated manufacturing units in the US, Europe, and Japan.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Adaptimmune Therapeutics plc

Bluebird Bio, Inc.

Catalent, Inc.

Celyad Oncology SA

Charles River Laboratories International, Inc.

Gene Therapy Research Group

Kiadis Pharma N.V.

Lonza Group AG

MaxCyte, Inc.

Miltenyi Biotec GmbH

Orchard Therapeutics plc

Rocket Pharmaceuticals, Inc.

Sangamo Therapeutics, Inc.

Sarepta Therapeutics, Inc.

TCR2 Therapeutics Inc.

WuXi AppTec

Others

GLOBAL CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET, BY THERAPY TYPE- MARKET ANALYSIS, 2019 - 2032

Cell Therapy
Gene Therapy

GLOBAL CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET, BY CELL TYPE- MARKET ANALYSIS, 2019 - 2032

Autologous Cells
Allogeneic Cells

GLOBAL CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET, BY SERVICE TYPE- MARKET ANALYSIS, 2019 - 2032

Contract Development and Manufacturing Organization (CDMO)
Contract Research Organization (CRO)
Manufacturing Technology Solutions

GLOBAL CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

Pharmaceutical Companies
Biotechnology Companies
Academic Institutions
Research Institutions

GLOBAL CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. Cell and Gene Therapy Manufacturing Services Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Cell and Gene Therapy Manufacturing Services Market Snippet by Therapy Type
- 2.1.2. Cell and Gene Therapy Manufacturing Services Market Snippet by Cell Type
- 2.1.3. Cell and Gene Therapy Manufacturing Services Market Snippet by Service Type
- 2.1.4. Cell and Gene Therapy Manufacturing Services Market Snippet by End-User
- 2.1.5. Cell and Gene Therapy Manufacturing Services Market Snippet by Country
- 2.1.6. Cell and Gene Therapy Manufacturing Services Market Snippet by Region
2.2. Competitive Insights

3. Cell and Gene Therapy Manufacturing Services Key Market Trends

3.1. Cell and Gene Therapy Manufacturing Services Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Cell and Gene Therapy Manufacturing Services Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Cell and Gene Therapy Manufacturing Services Market Opportunities
3.4. Cell and Gene Therapy Manufacturing Services Market Future Trends

4. Cell and Gene Therapy Manufacturing Services Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Cell and Gene Therapy Manufacturing Services Market: COVID-19 Impact Analysis

5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments

6. Cell and Gene Therapy Manufacturing Services Market Landscape

6.1. Cell and Gene Therapy Manufacturing Services Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Cell and Gene Therapy Manufacturing Services Market - By Therapy Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Therapy Type, 2023 & 2032 (%)
- 7.1.2. Cell Therapy
- 7.1.3. Gene Therapy

8. Cell and Gene Therapy Manufacturing Services Market - By Cell Type

8.1. Overview
- 8.1.1. Segment Share Analysis, By Cell Type, 2023 & 2032 (%)
- 8.1.2. Autologous Cells
- 8.1.3. Allogeneic Cells

9. Cell and Gene Therapy Manufacturing Services Market - By Service Type

9.1. Overview
- 9.1.1. Segment Share Analysis, By Service Type, 2023 & 2032 (%)
- 9.1.2. Contract Development and Manufacturing Organization (CDMO)
- 9.1.3. Contract Research Organization (CRO)
- 9.1.4. Manufacturing Technology Solutions

10. Cell and Gene Therapy Manufacturing Services Market - By End-User

10.1. Overview
- 10.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
- 10.1.2. Pharmaceutical Companies
- 10.1.3. Biotechnology Companies
- 10.1.4. Academic Institutions
- 10.1.5. Research Institutions

11. Cell and Gene Therapy Manufacturing Services Market- By Geography

11.1. Introduction
- 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
11.2. North America
- 11.2.1. Overview
- 11.2.2. Cell and Gene Therapy Manufacturing Services Key Manufacturers in North America
- 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.2.4. North America Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
- 11.2.5. North America Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
- 11.2.6. North America Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
- 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.2.8. U.S.
  - 11.2.8.1. Overview
  - 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.2.8.3. U.S. Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.2.8.4. U.S. Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
  - 11.2.8.5. U.S. Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.2.9. Canada
  - 11.2.9.1. Overview
  - 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.2.9.3. Canada Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.2.9.4. Canada Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
  - 11.2.9.5. Canada Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3. Europe
- 11.3.1. Overview
- 11.3.2. Cell and Gene Therapy Manufacturing Services Key Manufacturers in Europe
- 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.3.4. Europe Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
- 11.3.5. Europe Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
- 11.3.6. Europe Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
- 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.8. Germany
  - 11.3.8.1. Overview
  - 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.8.3. Germany Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.3.8.4. Germany Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
  - 11.3.8.5. Germany Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.9. Italy
  - 11.3.9.1. Overview
  - 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.9.3. Italy Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.3.9.4. Italy Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
  - 11.3.9.5. Italy Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.3.9.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.10. United Kingdom
  - 11.3.10.1. Overview
  - 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.10.3. United Kingdom Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.3.10.4. United Kingdom Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
  - 11.3.10.5. United Kingdom Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.3.10.6. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.11. France
  - 11.3.11.1. Overview
  - 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.11.3. France Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.3.11.4. France Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
  - 11.3.11.5. France Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.3.11.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.12. Russia
  - 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.12.2. Russia Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.3.12.3. Russia Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
  - 11.3.12.4. Russia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.3.12.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.13. Netherlands
  - 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.13.2. Netherlands Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.3.13.3. Netherlands Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
  - 11.3.13.4. Netherlands Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.3.13.5. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.14. Sweden
  - 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.14.2. Sweden Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.3.14.3. Sweden Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
  - 11.3.14.4. Sweden Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.3.14.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.15. Poland
  - 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.15.2. Poland Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.3.15.3. Poland Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
  - 11.3.15.4. Poland Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.16. Rest of Europe
  - 11.3.16.1. Overview
  - 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.16.3. Rest of the Europe Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.3.16.4. Rest of the Europe Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
  - 11.3.16.5. Rest of the Europe Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4. Asia Pacific (APAC)
- 11.4.1. Overview
- 11.4.2. Cell and Gene Therapy Manufacturing Services Key Manufacturers in Asia Pacific
- 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.4.4. Asia Pacific Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
- 11.4.5. Asia Pacific Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
- 11.4.6. Asia Pacific Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
- 11.4.7. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.8. India
  - 11.4.8.1. Overview
  - 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.8.3. India Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.4.8.4. India Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
  - 11.4.8.5. India Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.4.8.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.9. China
  - 11.4.9.1. Overview
  - 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.9.3. China Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.4.9.4. China Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
  - 11.4.9.5. China Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.4.9.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.10. Japan
  - 11.4.10.1. Overview
  - 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.10.3. Japan Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.4.10.4. Japan Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
  - 11.4.10.5. Japan Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.11. South Korea
  - 11.4.11.1. Overview
  - 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.11.3. South Korea Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.4.11.4. South Korea Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
  - 11.4.11.5. South Korea Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.12. Australia
  - 11.4.12.1. Overview
  - 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.12.3. Australia Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.4.12.4. Australia Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
  - 11.4.12.5. Australia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.13. Thailand
  - 11.4.13.1. Overview
  - 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.13.3. Thailand Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.4.13.4. Thailand Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
  - 11.4.13.5. Thailand Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.4.13.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.14. Indonesia
  - 11.4.14.1. Overview
  - 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.14.3. Indonesia Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.4.14.4. Indonesia Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
  - 11.4.14.5. Indonesia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.4.14.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.15. Philippines
  - 11.4.15.1. Overview
  - 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.15.3. Philippines Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.4.15.4. Philippines Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
  - 11.4.15.5. Philippines Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.16. Rest of APAC
  - 11.4.16.1. Overview
  - 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.16.3. Rest of APAC Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.4.16.4. Rest of APAC Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
  - 11.4.16.5. Rest of APAC Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.5. Latin America
- 11.5.1. Overview
- 11.5.2. Cell and Gene Therapy Manufacturing Services Key Manufacturers in Latin America
- 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.5.4. Latin America Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
- 11.5.5. Latin America Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
- 11.5.6. Latin America Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
- 11.5.7. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.5.8. Brazil
  - 11.5.8.1. Overview
  - 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.8.3. Brazil Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.5.8.4. Brazil Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
  - 11.5.8.5. Brazil Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.5.9. Mexico
  - 11.5.9.1. Overview
  - 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.9.3. Mexico Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.5.9.4. Mexico Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
  - 11.5.9.5. Mexico Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.5.10. Argentina
  - 11.5.10.1. Overview
  - 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.10.3. Argentina Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.5.10.4. Argentina Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
  - 11.5.10.5. Argentina Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.5.11. Colombia
  - 11.5.11.1. Overview
  - 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.11.3. Colombia Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.5.11.4. Colombia Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
  - 11.5.11.5. Colombia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.5.12. Rest of LATAM
  - 11.5.12.1. Overview
  - 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.12.3. Rest of LATAM Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.5.12.4. Rest of LATAM Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
  - 11.5.12.5. Rest of LATAM Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.6. Middle East and Africa
- 11.6.1. Overview
- 11.6.2. Cell and Gene Therapy Manufacturing Services Key Manufacturers in Middle East and Africa
- 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.6.4. Middle East and Africa Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
- 11.6.5. Middle East and Africa Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
- 11.6.6. Middle East and Africa Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
- 11.6.7. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.8. Saudi Arabia
  - 11.6.8.1. Overview
  - 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.8.3. Saudi Arabia Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.6.8.4. Saudi Arabia Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
  - 11.6.8.5. Saudi Arabia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.9. United Arab Emirates
  - 11.6.9.1. Overview
  - 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.9.3. United Arab Emirates Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.6.9.4. United Arab Emirates Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
  - 11.6.9.5. United Arab Emirates Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.10. Israel
  - 11.6.10.1. Overview
  - 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.10.3. Israel Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.6.10.4. Israel Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
  - 11.6.10.5. Israel Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.11. Turkey
  - 11.6.11.1. Overview
  - 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.11.3. Turkey Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.6.11.4. Turkey Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
  - 11.6.11.5. Turkey Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.12. Algeria
  - 11.6.12.1. Overview
  - 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.12.3. Algeria Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.6.12.4. Algeria Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
  - 11.6.12.5. Algeria Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.13. Egypt
  - 11.6.13.1. Overview
  - 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.13.3. Egypt Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.6.13.4. Egypt Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
  - 11.6.13.5. Egypt Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.14. Rest of MEA
  - 11.6.14.1. Overview
  - 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.14.3. Rest of MEA Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
  - 11.6.14.4. Rest of MEA Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
  - 11.6.14.5. Rest of MEA Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Cell and Gene Therapy Manufacturing Services Industry

12.1. Competitive Dashboard
12.2. Company Profiles
- 12.2.1. Adaptimmune Therapeutics plc
- 12.2.2. Bluebird Bio, Inc.
- 12.2.3. Catalent, Inc.
- 12.2.4. Celyad Oncology SA
- 12.2.5. Charles River Laboratories International, Inc.
- 12.2.6. Gene Therapy Research Group
- 12.2.7. Kiadis Pharma N.V.
- 12.2.8. Lonza Group AG
- 12.2.9. MaxCyte, Inc.
- 12.2.10. Miltenyi Biotec GmbH
- 12.2.11. Orchard Therapeutics plc
- 12.2.12. Rocket Pharmaceuticals, Inc.
- 12.2.13. Sangamo Therapeutics, Inc.
- 12.2.14. Sarepta Therapeutics, Inc.
- 12.2.15. TCR2 Therapeutics Inc.
- 12.2.16. WuXi AppTec
- 12.2.17. Others

13. 360 Degree Analyst View

14. Appendix

14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us